Omeprazol Medreg (Omeprazole)

Omeprazole irreversibly inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the surface of parietal cells in the stomach. By blocking this final step of acid secretion, it markedly lowers gastric acidity, providing symptom relief and allowing damaged tissue to heal.

The dosage of Omeprazol Medreg is determined by the prescribing healthcare professional based on the specific condition, severity, and patient characteristics. The prescriber will set the appropriate strength, frequency and duration of therapy.

Omeprazole is classified as pregnancy category C, meaning risk cannot be ruled out. It should only be used if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding; the drug does pass into breast milk in small amounts, so a risk‑benefit assessment is required.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details and any necessary import documentation.

Omeprazol Medreg belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may vary.

Omeprazol Medreg should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and store them out of reach of children.

Omeprazol Medreg is taken orally, usually as a whole tablet with a glass of water. It is generally recommended to take the dose before a meal, often in the morning, unless otherwise directed by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and long‑term complications like hypomagnesemia, vitamin B12 deficiency and increased risk of bone fractures. Patients should seek immediate medical attention if they experience rash, swelling, persistent diarrhea or muscle weakness.

Omeprazol Medreg is contraindicated in patients with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, those taking clopidogrel, and patients with a history of allergic reactions to proton pump inhibitors.